Frazier E.P., Isenberg J.S., Shiva S., Zhao L., Schlesinger P., Dimitry J., Abu-Asab M.S., Tsokoa M., Roberts D.D., & Frazier W.A. (2011). “Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.” Matrix Biol. 2011 Mar;30(2):154-61. doi: 10.1016/j.matbio.2010.12.004. Epub 2011 Jan 20. (Abstract)
Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., Lacy-Hulbert A., Khoury J.E., Golenbock D.T., & Moore K.J. (2010). “CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.” Nat Immunol. 2010 Feb;11(2):155-61. doi: 10.1038/ni.1836. Epub 2009 Dec 27. (Abstract)
Uluckan O., Becker S.N., Deng H., Zou W., Prior J.L., Piwnica-Worms D., Frazier W.A., & Weilbaecher K.N. (2009). “CD47 regulates bone mass and tumor metastasis to bone.” Cancer Res. 2009 Apr 1;69(7):3196-204. doi: 10.1158/0008-5472.CAN-08-3358. Epub 2009 Mar 10. (Abstract)
Isenberg J.S., Ridnour L.A., Dimitry J., Frazier W.A., Wink D.A., & Roberts D.D. (2006). “CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.” J Biol Chem. 2006 Sep 8;281(36):26069-80. Epub 2006 Jul 11. (Abstract)
Hagnerud S., Manna P.P., Cella M., Stenberg A., Frazier W.A., Colonna M., & Oldenborg P.A. (2006). “Deficit of CD47 results in a defect of marginal zone dendritic cells, blunted immune response to particulate antigen and impairment of skin dendritic cell migration.” J Immunol. 2006 May 15;176(10):5772-8. (Abstract)